Functional Heterogeneity of Osteopontin Isoforms in Non-Small Cell Lung Cancer

Por Goparaju, C.M.V., Pass, H.I., Blasberg, J.D., Hirsch, N., Donington, J.S.
Publicado em 2010

Development and Validation of a qRT-PCR Classifier for Lung Cancer Prognosis

Por Chen, Guoan, Kim, Sinae, Taylor, Jeremy MG, Wang, Zhuwen, Lee, Oliver, Ramnath, Nithya, Reddy, Rishindra M, Lin, Jules, Chang, Andrew C, Orringer, Mark B, Beer, David G
Publicado em 2011

Phase II Trial of Dasatinib for Patients with Acquired Resistance to Treatment with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Erlotinib or Gefitinib

Por Johnson, Melissa L., Riely, Greg J., Rizvi, Naiyer A., Azzoli, Christopher G., Kris, Mark G., Sima, Camelia S., Ginsberg, Michelle S., Pao, William, Miller, Vincent A.
Publicado em 2011

Exhaled Breath Analysis with a Colorimetric Sensor Array for the Identification and Characterization of Lung Cancer

Por Mazzone, Peter J, Wang, Xiao-Feng, Xu, Yaomin, Mekhail, Tarek, Beukemann, Mary C, Na, Jie, Kemling, Jonathan W, Suslick, Kenneth S, Sasidhar, Madhu
Publicado em 2012

Brief Report: Phase II Trial of Rebeccamycin Analogue, a Dual Topoisomerase I and II Inhibitor, in Relapsed “Sensitive” Small Cell Lung Cancer

Por Schwandt, Anita, Mekhail, Tarek, Halmos, Balazs, O'Brien, Timothy, Ma, Patrick C., Fu, Pingfu, Ivy, Percy, Dowlati, Afshin
Publicado em 2012

Phase I Study of Sunitinib and Erlotinib in Advanced Nonsquamous Non-small Cell Lung Cancer

Por O’Mahar, Shannon E., Campbell, Toby C., Hoang, Tien, Seo, Songwon, Kim, KyungMann, Larson, Martha M., Marcotte, Sarah M., LoConte, Noelle K., Traynor, Anne M.
Publicado em 2011

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Diagnosis of Intrathoracic Lymphadenopathy in Patients with Extrathoracic Malignancy: A Multicenter Study

Por Navani, Neal, Nankivell, Matthew, Woolhouse, Ian, Harrison, Richard N., Munavvar, Mohammed, Oltmanns, Ute, Falzon, Mary, Kocjan, Gabrijela, Rintoul, Robert C., Janes, Sam M.
Publicado em 2011

Physician Preferences for Management of Patients with Stage IIIA NSCLC: Impact of Bulk of Nodal Disease on Therapy Selection

Por Tanner, Nichole T., Gomez, Mario, Rainwater, Chelsea, Nietert, Paul J., Simon, George R., Green, Mark R., Silvestri, Gerard A.
Publicado em 2012

BRIEF REPORT: CHARACTERIZATION AND MANAGEMENT OF CARDIAC INVOLVEMENT OF THYMIC EPITHELIAL TUMORS

Por Thomas, Anish, Shanbhag, Sujata, Haglund, Karl, Berman, Arlene, Jakopovic, Marko, Szabo, Eva, Arai, Andrew, Schrump, David S., Kwong, King F., Rajan, Arun, Giaccone, Giuseppe
Publicado em 2013

Lung Volume Measurements as a Surrogate Marker for Patient Response in Malignant Pleural Mesothelioma

Por Labby, Zacariah E., Armato, Samuel G., Dignam, James J., Straus, Christopher, Kindler, Hedy L., Nowak, Anna K.
Publicado em 2013

Practice Patterns and Perceptions of Thoracic Oncology Providers on Tobacco Use and Cessation in Cancer Patients

Por Warren, Graham W., Marshall, James R., Cummings, K. Michael, Toll, Benjamin, Gritz, Ellen R., Hutson, Alan, Dibaj, Seyedeh, Herbst, Roy, Dresler, Carolyn
Publicado em 2013

Clinical outcomes with perioperative chemotherapy in sarcomatoid carcinomas of the lung

Por Chaft, Jamie E., Sima, Camelia S., Ginsberg, Michelle S., Huang, James, Kris, Mark G., Travis, William D., Azzoli, Christopher G.
Publicado em 2012

Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients with Unresectable Esophageal and Gastroesophageal Adenocarcinoma

Por Lustberg, Maryam B., Bekaii-Saab, Tanios, Young, Donn, Otterson, Gregory, Burak, William, Abbas, Abbas, McCracken-Bussa, Barbara, Lustberg, Mark E., Villalona-Calero, Miguel A.
Publicado em 2010

EZH2 promotes E2F driven SCLC tumorigenesis through modulation of apoptosis and cell cycle regulation

Por Hubaux, Roland, Thu, Kelsie L., Coe, Bradley P., MacAulay, Calum, Lam, Stephen, Lam, Wan L.
Publicado em 2013

PHASE II STUDY OF CELECOXIB AND DOCETAXEL IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH PROGRESSION AFTER PLATINUM-BASED THERAPY

Por Schneider, Bryan J., Kalemkerian, Gregory P., Kraut, Michael J., Wozniak, Antoinette J., Worden, Francis P., Smith, Daryn W., Chen, Wei, Gadgeel, Shirish M.
Publicado em 2008

A phase II study of sorafenib in malignant mesothelioma: results of CALGB 30307

Por Dubey, Sarita, Jänne, Pasi A., Krug, Lee, Pang, Herbert, Wang, Xiaofei, Heinze, Robin, Watt, Colleen, Crawford, Jeff, Kratzke, Robert, Vokes, Everett, Kindler, Hedy Lee
Publicado em 2010

Contributions of KRAS and RAL in Non-Small Cell Lung Cancer growth and progression

Por Guin, Sunny, Ru, Yuanbin, Wynes, Murry W., Mishra, Rangnath, Lu, Xian, Owens, Charles, Barόn, Anna E., Vasu, Vihas T., Hirsch, Fred R., Kern, Jeffrey A., Theodorescu, Dan
Publicado em 2013

Bortezomib, Paclitaxel, and Carboplatin as a First-Line Regimen for Patients with Metastatic Esophageal, Gastric, and Gastroesophageal Cancer: Phase II Results from the North Centr...

Por Jatoi, Aminah, Dakhil, Shaker R., Foster, Nathan R., Ma, Cynthia, Rowland, Kendrith M., Moore, Dennis F., Jaslowski, Anthony J., Thomas, Sachdev P., Hauge, Mark D., Flynn, Patrick J., Stella, Philip J., Alberts, Steven R.
Publicado em 2008

Stage-adjusted Lung Cancer Survival Does Not Differ Between Low-Income Blacks and Whites

Por Aldrich, Melinda C., Grogan, Eric L., Munro, Heather M., Signorello, Lisa B., Blot, William J.
Publicado em 2013

The Effects of Chemotherapy on Survival of Elderly Patients with Small Cell Lung Cancer: Analysis of the SEER-Medicare Database

Por Caprario, Laura C.
Publicado em 2013